VitaStem VITASTEM in Allora ALLO tauschen

VitaSTEM — The first AI-enabled longevity project and inaugural IP-Token launched by Aubrai, VitaDAO’s decentralized scientific agent. After six months of deep research on public and proprietary single-cell RNA-seq and multi-omics datasets, our scientific research team analyzed more than 850,000 human hematopoietic stem cell transcriptomes from donors aged 23–91 (both male and female). This effort uncovered 100+ high-potential rejuvenation target genes and revealed critical drivers of decline such as RhoA hyperactivation, CD38 upregulation, and CCR9 downregulation. Rather than treating HSC aging as a single defect, Aubrai recognized it as convergent damage across interconnected systems, generating a comprehensive multi-modal, five-phase rejuvenation protocol targeting transcriptional stress, metabolic dysfunction, and epigenetic drift in parallel. The agent shortlisted target genes using insights from thousands of peer-reviewed publications and private data and also optimized experimental protocols to guide in vitro and upcoming pre-clinical testing. For the first time, human researchers and AI Agents collaborate as co-scientists in the creation of pioneering scientific IP.

ALLO ist der native Utility- und Governance-Token des Allora-Protokolls, einer dezentralen KI-Plattform, die auf der Cosmos Layer-1-Blockchain aufgebaut ist. Allora zielt darauf ab, ein kollaboratives und sich kontinuierlich verbesserndes Ökosystem für maschinelles Lernen zu schaffen, in dem verschiedene Modelle, Datenbeiträger und Validatoren gemeinsam sichere und fortschrittliche KI-Ergebnisse generieren.​